Division of Pathology, Shizuoka Cancer Center, Shizuoka.
Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Am J Surg Pathol. 2022 Mar 1;46(3):383-391. doi: 10.1097/PAS.0000000000001822.
Invasive lobular carcinoma (ILC) of the breast is characterized by the discohesive growth of tumor cells, which is mainly associated with the complete loss of E-cadherin (E-cad) expression. However, some aberrant expression patterns of E-cad protein that are inconsistent with their morphologies have been reported in ILC. We report herein ILC cases expressing a new type of abnormal E-cad protein that lacks the N-terminal domain, but conserves the C-terminal domain on the cell membrane. Immunohistochemical staining of 299 ILC cases using specific antibodies against the N-terminal or C-terminal region of E-cad revealed that 227 (76%) cases showed loss of the membranous expression of both terminuses (N-/C-) and 72 (24%) cases showed expression of only the C-terminus (N-/C+). In all cases, the expression of p120-catenin and β-catenin coincided with the expression of the C-terminus of E-cad. Clinicopathologic analysis revealed that N-/C+ expression in ILC cells was significantly associated with the histologic subtype (especially mixed-type ILC with another histologic type) and immunohistochemical molecular subtype (especially the triple-negative subtype), but not with prognostic factors (pT or pN). In addition, 12 of 15 cases (80%) with aberrant cytoplasmic localization of the N-terminal of E-cad showed diffuse membranous expression of the C-terminal domain. Additional immunohistochemistry using an antibody recognizing the extracellular juxtamembrane region showed that 28 (39%) of the N-/C+ cases had lost membranous expression, suggesting diversity in the deletion pattern of the N-terminal region. Our findings provide a novel mechanism for the loss of E-cad function because of N-terminal-deficient E-cad protein in ILC.
乳腺浸润性小叶癌(ILC)的特征是肿瘤细胞的离散生长,这主要与 E-钙黏蛋白(E-cad)表达的完全缺失有关。然而,在 ILC 中已经报道了一些与形态不一致的 E-钙蛋白异常表达模式。我们在此报告了表达新型异常 E-钙蛋白的 ILC 病例,该蛋白缺乏 N 端结构域,但在细胞膜上保留 C 端结构域。使用针对 E-cad 的 N 端或 C 端区域的特异性抗体对 299 例 ILC 病例进行免疫组织化学染色,结果显示 227 例(76%)病例均表现为两个末端(N-/C-)的膜表达缺失,72 例(24%)病例仅表现为 C 端(N-/C+)表达。在所有病例中,p120-连环蛋白和β-连环蛋白的表达与 E-cad 的 C 端表达一致。临床病理分析显示,ILC 细胞中的 N-/C+表达与组织学亚型(尤其是另一种组织学类型的混合性 ILC)和免疫组织化学分子亚型(尤其是三阴性亚型)显著相关,但与预后因素(pT 或 pN)无关。此外,15 例异常 E-cad 胞质内定位的病例中有 12 例(80%)显示 C 端的弥漫膜表达。使用识别细胞外连接膜区的抗体进行的额外免疫组织化学分析显示,28 例(39%)N-/C+病例丧失了膜表达,表明 N 端区域缺失模式存在多样性。我们的发现提供了一个新的机制,即 ILC 中 N 端缺失的 E-cad 蛋白导致 E-cad 功能丧失。